Risiko og usikkerhetsmomenter ved transfusjoner

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (åpner nytt vindu)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Kilde‎: Surgery 2012;152(3):344-54.

Arkiv‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (åpner nytt vindu)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (åpner nytt vindu)

Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB.

Kilde‎: Arch Surg 2012;147(1):49-55.

Arkiv‎: PubMed 22250113

DOI‎: 10.1001/archsurg.2011.790

https://www.ncbi.nlm.nih.gov/pubmed/22250113 (åpner nytt vindu)

Adverse blood transfusion outcomes: establishing causation. (åpner nytt vindu)

Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A.

Kilde‎: Transfus Med Rev 2011;25(2):89-101.

Arkiv‎: PubMed 21345639

DOI‎: 10.1016/j.tmrv.2010.11.001

https://www.ncbi.nlm.nih.gov/pubmed/21345639 (åpner nytt vindu)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (åpner nytt vindu)

Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH.

Kilde‎: Crit Care Med 2006;34(6):1608-16.

Arkiv‎: PubMed 16607235

DOI‎: 10.1097/01.CCM.0000217920.48559.D8

https://www.ncbi.nlm.nih.gov/pubmed/16607235 (åpner nytt vindu)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (åpner nytt vindu)

Marik PE, Corwin HL.

Kilde‎: Crit Care Med 2008;36(9):2667-74.

Arkiv‎: PubMed 18679112

DOI‎: 10.1097/CCM.0b013e3181844677

https://www.ncbi.nlm.nih.gov/pubmed/18679112 (åpner nytt vindu)

Survival rate changes with transfusion of blood products during liver transplantation. (åpner nytt vindu)

Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A.

Kilde‎: Can J Anaesth 2005;52(2):148-55.

Arkiv‎: PubMed 15684254

DOI‎: 10.1007/BF03027720

https://www.ncbi.nlm.nih.gov/pubmed/15684254 (åpner nytt vindu)

Emerging infectious disease agents and their potential threat to transfusion safety. (åpner nytt vindu)

Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY.

Kilde‎: Transfusion 2009;49 Suppl 2:1S-29S.

Arkiv‎: PubMed 19686562

DOI‎: 10.1111/j.1537-2995.2009.02279.x

https://www.ncbi.nlm.nih.gov/pubmed/19686562 (åpner nytt vindu)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (åpner nytt vindu)

Stramer SL.

Kilde‎: ISBT Sci Ser 2014;9(1):30-6.

Arkiv‎: PubMed 25210533

DOI‎: 10.1111/voxs.12070

https://www.ncbi.nlm.nih.gov/pubmed/25210533 (åpner nytt vindu)

PERIOPERATIV BEHANDLING

Risiko og usikkerhetsmomenter ved transfusjoner

Norsk

Risiko og usikkerhetsmomenter ved transfusjoner

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Risiko og usikkerhetsmomenter ved transfusjoner

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (åpner nytt vindu)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (åpner nytt vindu)

Adverse blood transfusion outcomes: establishing causation. (åpner nytt vindu)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (åpner nytt vindu)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (åpner nytt vindu)

Survival rate changes with transfusion of blood products during liver transplantation. (åpner nytt vindu)

Emerging infectious disease agents and their potential threat to transfusion safety. (åpner nytt vindu)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (åpner nytt vindu)

Sykehuskontaktutvalg (SKU)

Medisinsk informasjonsmateriale

Videoer

Intervju med lege Pia Di Benedetto

Risiko og usikkerhetsmomenter ved transfusjoner

Velg ditt språk

Del